Acipam 10 mg (Tablet)
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Escitalopram oxalate |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Indications
- Treatment of major depressive episodes
- Treatment of panic disorder with or without agoraphobia
- Treatment of social anxiety disorder (social phobia)
- Treatment of generalised anxiety disorder
- Treatment of obsessive-compulsive disorder
Pharmacology
- Selective serotonin reuptake inhibitor (SSRI)
- Pure S-enantiomer of racemic bicyclic phthalate derivative citalopram
- At least 100 fold more potent than the R-enantiomer in inhibiting 5-HT reuptake
- Low affinity for serotonergic or other receptors including alpha- and beta-adrenergic Dopamine, Histamine, Muscarinic and benzodiazepine receptors
Dosage
- Usual dosage is 10 mg once daily for major depressive episodes
- Initial dose of 5 mg recommended for panic disorder with or without agoraphobia
- Usual dosage is 10 mg once daily for social anxiety disorder
- Initial dosage is 10 mg once daily for generalised anxiety disorder
- Initial dosage is 10 mg once daily for obsessive-compulsive disorder
Administration
- Administered once daily, morning or evening with or without food
Interaction
- SSRI or related antidepressants should not be started until 2 weeks after stopping an MAOI
- An MAOI should not be started until at least a week after an SSRI or related antidepressant has been stopped
Contraindications
- Contraindicated in patients with known hypersensitivity to Escitalopram or Citalopram or any of the inactive ingredients of the drug product
- Concomitant use of escitalopram in patients taking monoamine oxidase/pimozide is contraindicated
Side Effects
- Less sedating and have fewer antimuscarinic and cardiotoxic effects than tricyclic antidepressants
- Common side-effects include nausea, vomiting, dyspepsia, abdominal pain, diarrhoea, constipation, anorexia with weight loss, hypersensitivity reactions, dry mouth, nervousness, anxiety, headache, insomnia, tremor, dizziness
- Other side-effects include asthenia, hallucinations, drowsiness, convulsions, sexual dysfunction, urinary retention, sweating, hypomania or mania, movement disorders, dyskinesias, visual disturbances
Pregnancy & Lactation
- Consider potential risks and benefits of treatment when treating a pregnant woman with Escitalopram during the third trimester
- Excreted in human breast milk, weigh risk of exposure for the infant and benefits of treatment for the mother
Precautions & Warnings
- Use with caution in patients with epilepsy, cardiac disease, diabetes mellitus, angle-closure glaucoma, history of mania, concurrent electroconvulsive therapy, hepatic and renal impairment
- Avoid use if poorly controlled epilepsy, discontinue if convulsions develop
Use in Special Populations
- Elderly patients (>65 years of age): Initial dosage is 5 mg once daily
- Use not recommended in children and adolescents (<18 years)
- Dosage adjustment not necessary in patients with mild or moderate renal impairment
- Caution advised in patients with severely reduced renal function, and hepatic function
- Initial dose of 5 mg daily for the first two weeks recommended in patients with mild or moderate hepatic impairment
- For patients known to be poor metabolisers with respect to CYP2C19, an initial dose of 5 mg daily during the first two weeks of treatment is recommended
Overdose Effects
- Symptoms may include dizziness, tremor, agitation, serotonin syndrome, convulsion, coma, nausea/vomiting, hypotension, tachycardia, QT interval prolongation, arrhythmia, electrolyte/fluid balance conditions
- No specific antidote, general symptomatic supportive measures recommended
Therapeutic Class
- SSRIs & related anti-depressant drugs
Storage Conditions
- Store below 30°C temperature and protect from light & moisture
- Keep the medicine out of the reach of children